Viewing Study NCT06103266


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2025-12-29 @ 11:34 AM
Study NCT ID: NCT06103266
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-10-26
First Post: 2023-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention
Sponsor: J.P.S Henriques
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-01
Start Date Type: ESTIMATED
Primary Completion Date: 2025-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12
Completion Date Type: ESTIMATED
First Submit Date: 2023-10-22
First Submit QC Date: None
Study First Post Date: 2023-10-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-10-22
Last Update Post Date: 2023-10-26
Last Update Post Date Type: ACTUAL